Related Experiment Video
Updated: Feb 23, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational
Olufunso W Odunukan1, Matthew J Price1
1Division of Cardiovascular Diseases, Scripps Clinic, 9898 Genesee Avenue, La Jolla, CA 92037, USA.
Insights
Patent foramen ovale (PFO) is common in cryptogenic stroke patients. This review assesses PFO closure
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Cryptogenic strokes account for about one-third of all strokes.
- Patent foramen ovale (PFO) is found in up to 60% of cryptogenic stroke patients, a higher prevalence than in the general population.
- Potential mechanisms for stroke in PFO patients include paradoxical embolism and in situ thrombosis.
Purpose of the Study:
- To review and critically evaluate current research.
- To assess the efficacy and safety of patent foramen ovale closure.
- To determine the role of PFO closure in preventing recurrent cryptogenic strokes.
Main Methods:
- Systematic review and critical appraisal of contemporary studies.
- Analysis of data on PFO closure procedures.
- Evaluation of stroke recurrence rates and safety outcomes post-closure.
Main Results:
- Studies indicate a significant association between PFO and cryptogenic stroke.
- Efficacy data on PFO closure for stroke prevention is being actively investigated.
- Safety profiles of PFO closure interventions are a key consideration.
Conclusions:
- Patent foramen ovale closure is a potential strategy for preventing recurrent cryptogenic strokes.
- Further research is needed to definitively establish the efficacy and optimal patient selection for PFO closure.
- Balancing the benefits of stroke prevention against procedural risks is crucial.
Abstract:
Approximately one-third of all strokes have no apparent cause. A patent foramen ovale (PFO) is present in as many as 60% of these patients with cryptogenic strokes, which is significantly more frequent than that of the general population. The presumed biologic mechanisms of ischemic stroke in the setting of a PFO are paradoxic embolism from the peripheral venous system through this interatrial shunt or embolism from in situ thrombosis. In this review, the authors summarize and critically assess the contemporary studies evaluating the efficacy and safety of PFO closure for prevention of recurrent cryptogenic strokes.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Clinical Trials: Overview

